Category: Medical
-

STAT+: Why is Eli Lilly worth nearly $1 trillion?
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-

STAT+: Pharmalittle: We’re reading about FDA naming Pazdur as top drug regulator, a cancer drug gold rush, and more
•
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and…
-

STAT+: How two top FDA officials are quietly upending vaccine regulations
•
WASHINGTON — Health secretary Robert F. Kennedy Jr. has said he does not want to take vaccines away…
-

STAT+: Richard Pazdur, longtime cancer regulator, named drug center director at FDA
•
WASHINGTON — The Food and Drug Administration on Tuesday named Richard Pazdur, its longtime overseer of cancer therapies,…
-

STAT+: At ‘hush-hush’ MAHA summit, RFK Jr. and deputies to mix with biotech leaders
•
WASHINGTON — Health secretary Robert F. Kennedy Jr. and many top deputies are scheduled to speak alongside industry…
-

STAT+: Chinese government’s support for biotech fuels huge rally
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-

STAT+: Pharmalittle: We’re reading about hormone therapy warnings, U.K. animal research plans, and more
•
Rise and shine, everyone, another busy day is on the way. And it is getting off to a…
-

STAT+: A lot could be different by the next Liver Meeting
•
This is the final online version of this year’s AASLD in 30 Seconds, an e-mail newsletter from the…
-

STAT+: China’s biotech boom is being driven by a dazzling market rebound
•
Biotech is booming in China, and that’s no accident. While the most closely tracked U.S. index of biotech…
-

STAT+: What Pfizer’s Metsera deal means for biotech M&A
•
Mergers and acquisitions are a spectator sport. You couldn’t hope for a better match to watch than the…
-

STAT+: Medicaid’s ‘GENEROUS’ pricing may not save states money
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-

STAT+: Pharmalittle: We’re reading about a Merck cholesterol pill, the Trump deal for obesity drugs, and more
•
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating,…
-

STAT+: Is the White House’s deal with pharma on GLP-1 drugs a game changer?
•
President Trump last week hailed his deal with pharma companies to cut the price of blockbuster weight loss…
-

STAT+: Merck’s pill to reduce cholesterol on top of statins matches results from injectables
•
NEW ORLEANS — A pill designed to further lower cholesterol in people already on statins but at risk…
-

STAT+: Amgen’s cholesterol shot prevented first heart attacks and strokes, more detailed data affirm
•
NEW ORLEANS — A cholesterol-lowering injection that’s been on the market for nearly a decade has now shown…
-

Pfizer beats out Novo in bidding war for obesity-drug startup Metsera
•
Pfizer has won the bidding war against Novo Nordisk to acquire obesity-drug biotech Metsera. The pharma giant upped…
Recent Posts
- How March Madness foes can end UConn’s run through bracket
- Tournament bets: 12-over-5 upset pick and the 2-seed with clearest path to Elite Eight
- March Madness: Odds, spreads and totals for every men’s opening round games
- One Battle After Another’s big night: Key takeaways from the 2026 Oscars
- Liberia: LDEA Seizes Drugs Worth L$7.77 Million At Ganta Border – Guinean National Arrested
- Nigeria: Why I Didn’t Panic After Losing Power – Sanusi
- Liberia: Police Declare Jackson’s Home ‘Restricted’ As Crime Scene Reconstruction Continues in Wife’s Death Probe
- Liberia: NCD Launches Historic Nationwide Tour to Assess Needs of Persons With Disabilities
- Liberia: CDC Raises Concern Over Foya Border Tension and Accuses Government of Risking National Peace
- Nigeria: 2027 – Tinubu Directs His Campaign Group to Donate Rice to Nigerians for Ramadan, Lent
- Nigeria: Mining Dispute – Govt Accuses Jupiter Ltd of Smear Campaign Plot During Tinubu’s UK Visit
- Nigeria: Nigerian Govt Denies ‘British Lithium Project’ Seizure, Alleges Smear Campaign Ahead of Tinubu’s UK Visit
Social Media
Advertisement




